Guy-Charles Fanneau de la Horie
Director/Board Member at GENFLOW BIOSCIENCES PLC
Net worth: 9 861 $ as of 29/06/2024
Guy-Charles Fanneau de la Horie active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENFLOW BIOSCIENCES PLC | Director/Board Member | 28/06/2022 | - |
| Independent Dir/Board Member | 28/06/2022 | - | |
| PHARNEXT SCA | Director/Board Member | 09/07/2023 | - |
Career history of Guy-Charles Fanneau de la Horie
Former positions of Guy-Charles Fanneau de la Horie
| Companies | Position | Start | End |
|---|---|---|---|
| PHERECYDES PHARMA | Chief Executive Officer | 31/03/2016 | 18/05/2022 |
| NEOVACS | Director/Board Member | 21/09/2011 | 16/10/2013 |
| Chief Executive Officer | 10/04/2007 | 16/10/2013 | |
PathoQuest SAS
 PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | Chief Executive Officer | - | - |
| NANOBIOTIX | Director/Board Member | - | - |
Training of Guy-Charles Fanneau de la Horie
| INSEAD | Masters Business Admin |
Statistics
International
| France | 7 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| NEOVACS | Health Technology |
| NANOBIOTIX | Health Technology |
| GENFLOW BIOSCIENCES PLC | Health Technology |
| PHARNEXT SCA | Health Technology |
| Private companies | 2 |
|---|---|
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
PathoQuest SAS
PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | Health Technology |
